| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014078521 |
| P356 | DOI | 10.1007/S11481-007-9099-6 |
| P932 | PMC publication ID | 2566785 |
| P698 | PubMed publication ID | 18210200 |
| P5875 | ResearchGate publication ID | 5641931 |
| P50 | author | Lingdong Quan | Q114399451 |
| Alexander Kabanov | Q4206547 | ||
| P2093 | author name string | Xiang Yi | |
| Jamie L Gilmore | |||
| P2860 | cites work | Transition of cationic dipeptide nanotubes into vesicles and oligonucleotide delivery | Q79844612 |
| Peptide amphiphile nanofibers template and catalyze silica nanotube formation | Q79992877 | ||
| Fabrication of protein nanotubes based on layer-by-layer assembly | Q80232344 | ||
| Template-synthesized DNA nanotubes | Q81846957 | ||
| [Micelle carrier system in clinical trial] | Q82454544 | ||
| Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers | Q95443295 | ||
| Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass | Q24815080 | ||
| Biohybrid nanosystems with polymer nanofibers and nanotubes | Q28245408 | ||
| Albumin-bound paclitaxel: a next-generation taxane | Q29027108 | ||
| Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants | Q29615643 | ||
| Drug delivery systems: entering the mainstream | Q29618136 | ||
| Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. | Q30476979 | ||
| Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery | Q30479638 | ||
| Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents | Q30645462 | ||
| Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. | Q30667415 | ||
| Targeted polymeric micelles for delivery of poorly soluble drugs | Q30975425 | ||
| Structure by design: from single proteins and their building blocks to nanostructures | Q33255443 | ||
| Reactive microgliosis | Q33604483 | ||
| Nanogels for oligonucleotide delivery to the brain | Q33725062 | ||
| Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. | Q33726019 | ||
| Brain-specific expression of an exogenous gene after i.v. administration | Q33948080 | ||
| Drug targeting to the brain. | Q33999344 | ||
| Block copolymer micelles for drug delivery: design, characterization and biological significance | Q34184381 | ||
| Selective differentiation of neural progenitor cells by high-epitope density nanofibers | Q34291910 | ||
| Polyamidoamine cascade polymers mediate efficient transfection of cells in culture | Q34347285 | ||
| Colonisation of the human central nervous system by microglia: the roles of chemokines and vascular adhesion molecules. | Q34361515 | ||
| Carboxyfullerenes as neuroprotective agents. | Q34435342 | ||
| Turnover of resident microglia in the normal adult mouse brain | Q34435397 | ||
| Developments in liposomal drug delivery systems | Q34452675 | ||
| The emerging field of nanotube biotechnology | Q34530172 | ||
| Nanoparticle technology for drug delivery across the blood-brain barrier | Q34540557 | ||
| PEG-based micelles as carriers of contrast agents for different imaging modalities | Q34565347 | ||
| Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers | Q34669073 | ||
| Conducting-Polymer Nanotubes for Controlled Drug Release. | Q34941079 | ||
| Epidemiology of neurodegeneration | Q35062651 | ||
| The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse | Q48245374 | ||
| Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells | Q48364359 | ||
| Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates | Q48676851 | ||
| Carbon nanotube substrates boost neuronal electrical signaling | Q48863946 | ||
| Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies | Q49069202 | ||
| Impact of carbon nanotube exposure, dosage and aggregation on smooth muscle cells. | Q51073292 | ||
| Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides | Q51442592 | ||
| Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery | Q53524667 | ||
| Controlled electrochemical synthesis of conductive polymer nanotube structures. | Q53575578 | ||
| Nanomaterials: A Membrane-Based Synthetic Approach | Q55983088 | ||
| Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages | Q56794691 | ||
| Reactivity of carbon nanotubes: Free radical generation or scavenging activity? | Q56834674 | ||
| Nanomaterials from Ionic Block Copolymers and Single-, Double-, and Triple-Tail Surfactants | Q57375700 | ||
| Vector-mediated drug delivery to the brain | Q57677405 | ||
| Light-Harvesting Dendrimers: Efficient Intra- and Intermolecular Energy-Transfer Processes in a Species Containing 65 Chromophoric Groups of Four Different Types | Q61823062 | ||
| Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro | Q62391146 | ||
| The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting | Q69406237 | ||
| Water-soluble block polycations as carriers for oligonucleotide delivery | Q71017391 | ||
| Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agents | Q73169809 | ||
| Fullerene-based antioxidants and neurodegenerative disorders | Q73824888 | ||
| Plasma-etched nanopore polymer films and their use as templates to prepare "nano test tubes" | Q79760367 | ||
| Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview. | Q35166579 | ||
| Cerebrometabolic abnormalities in Alzheimer's disease | Q35540355 | ||
| Altering the properties of the blood-brain barrier: disruption and permeabilization | Q35607492 | ||
| Polymeric micelles for delivery of poorly water-soluble compounds | Q35665896 | ||
| Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system | Q36088651 | ||
| Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases | Q36302045 | ||
| Transepithelial and endothelial transport of poly (amidoamine) dendrimers | Q36313591 | ||
| Dendrimers in biomedical applications--reflections on the field | Q36321345 | ||
| Dendrimer-drug interactions. | Q36323316 | ||
| Polymeric micelles for drug delivery | Q36349714 | ||
| Dendrimers for pharmaceutical and biomedical applications | Q36367723 | ||
| Pros and cons of the liposome platform in cancer drug targeting | Q36585613 | ||
| Carbon nanotubes as nanomedicines: from toxicology to pharmacology | Q36657144 | ||
| Colloidal microgels in drug delivery applications | Q36683664 | ||
| Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer | Q36694177 | ||
| Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin | Q36696233 | ||
| Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics | Q36755348 | ||
| A macrophage-nanozyme delivery system for Parkinson's disease | Q37179637 | ||
| Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery | Q37263021 | ||
| Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer | Q40184020 | ||
| Polymerization of the conducting polymer poly(3,4-ethylenedioxythiophene) (PEDOT) around living neural cells | Q40196378 | ||
| Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. | Q40315666 | ||
| Cerium and yttrium oxide nanoparticles are neuroprotective | Q40316076 | ||
| Biomolecular applications of carbon nanotubes | Q40351844 | ||
| Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. | Q40446521 | ||
| Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer. | Q40547368 | ||
| Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering | Q40596634 | ||
| Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay | Q41733888 | ||
| Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles | Q44386469 | ||
| RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting | Q44523982 | ||
| Preparation of bionanoreactor based on core-shell structured polyion complex micelles entrapping trypsin in the core cross-linked with glutaraldehyde | Q44802181 | ||
| Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies | Q44918003 | ||
| Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases | Q45231701 | ||
| Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides. | Q45858295 | ||
| Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. | Q45865211 | ||
| Polyion complex micelles as vectors in gene therapy--pharmacokinetics and in vivo gene transfer | Q45885280 | ||
| Template-synthesized protein nanotubes. | Q46407611 | ||
| PEGylated immunoliposomes directed against brain astrocytes | Q46413840 | ||
| Colloidal stability of aqueous dispersions of block ionomer complexes: effects of temperature and salt | Q46441595 | ||
| Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease | Q46603774 | ||
| Block ionomer complexes as prospective nanocontainers for drug delivery. | Q46674539 | ||
| Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia | Q47764327 | ||
| In vivo expression of green fluorescent protein gene and immunogenicity of ES312 vaccine both mediated by starburst polyamidoamine dendrimers | Q48016353 | ||
| Neurite outgrowths of neurons with neurotrophin-coated carbon nanotubes | Q48202866 | ||
| MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease | Q48219980 | ||
| P433 | issue | 2 | |
| P921 | main subject | nanomaterial | Q967847 |
| P304 | page(s) | 83-94 | |
| P577 | publication date | 2008-01-22 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Neuroimmune Pharmacology | Q6295645 |
| P1476 | title | Novel nanomaterials for clinical neuroscience | |
| P478 | volume | 3 |
| Q61448145 | Advances in Nano Neuroscience: From Nanomaterials to Nanotools |
| Q49017113 | Analysis of Biotinylated Generation 4 Poly(amidoamine) (PAMAM) Dendrimer Distribution in the Rat Brain and Toxicity in a Cellular Model of the Blood-Brain Barrier |
| Q37994787 | Angiotensin-Generated Reactive Oxygen Species in Brain and Pathogenesis of Cardiovascular Diseases |
| Q38006650 | Application of carbon nanotubes in neurology: clinical perspectives and toxicological risks |
| Q37018785 | Biocompatability of carbon nanotubes with stem cells to treat CNS injuries |
| Q38065953 | Biofunctionalized carbon nanotubes in neural regeneration: a mini-review |
| Q38995079 | Biologically synthesized silver nanoparticles induce neuronal differentiation of SH-SY5Y cells via modulation of reactive oxygen species, phosphatases, and kinase signaling pathways. |
| Q38082519 | Brain Stem NOS and ROS in Neural Mechanisms of Hypertension |
| Q30354932 | Brain delivery of proteins via their fatty acid and block copolymer modifications |
| Q38546480 | Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery. |
| Q38034968 | Carbon nanotubes: artificial nanomaterials to engineer single neurons and neuronal networks |
| Q38016724 | Colloidal systems for drug delivery: from design to therapy |
| Q40167936 | Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles. |
| Q54373871 | DNA amplification via polymerase chain reaction inside miniemulsion droplets with subsequent poly(n-butylcyanoacrylate) shell formation and delivery of polymeric capsules into mammalian cells |
| Q48591905 | Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain |
| Q48696940 | Dendrimer D5 is a Vector for Peptide Transport to Brain Cells |
| Q38939522 | Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug. |
| Q59128922 | Diagnosis and Treatment of Neurological and Ischemic Disorders Employing Carbon Nanotube Technology |
| Q37906639 | Effect of Chemical Composition and State of The Surface on The Toxic Response to High Aspect Ratio Nanomaterials |
| Q46123768 | Effect of fullerenes C60 on the activity of pyramidal neurons in the CA1 field of rat hippocampal slices |
| Q39338888 | Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line |
| Q30401360 | Enhancement of Blood-Brain Barrier Permeability and Delivery of Antisense Oligonucleotides or Plasmid DNA to the Brain by the Combination of Bubble Liposomes and High-Intensity Focused Ultrasound |
| Q37430753 | Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma |
| Q57340480 | Functional Nanomaterials for Multifarious Nanomedicine |
| Q37294436 | Highly Conductive Carbon Nanotube Matrix Accelerates Developmental Chloride Extrusion in Central Nervous System Neurons by Increased Expression of Chloride Transporter KCC2 |
| Q36419960 | Hydrogel matrix to support stem cell survival after brain transplantation in stroke. |
| Q90641955 | Imaging of intranasal drug delivery to the brain |
| Q38880298 | Inhibition of β-amyloid peptide self-assembly and cytotoxicity by poly(LVFF-co-β-amino ester). |
| Q39658288 | Multifunctional Peptide-PEG Intercalating Conjugates: Programmatic of Gene Delivery to the Blood-Brain Barrier |
| Q37538776 | NanoART, neuroAIDS and CNS drug delivery |
| Q89910191 | Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances |
| Q38330408 | Nanomaterial applications in multiple sclerosis inflamed brain |
| Q39733465 | Nanomaterials in controlled drug release |
| Q57570763 | Nanoparticle Functionalization for Brain Targeting Drug Delivery and Diagnostic |
| Q47442352 | Nanoparticle-Based Therapeutics for Brain Injury |
| Q57341436 | Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping. |
| Q38201415 | Nanotechnology for the detection and therapy of stroke. |
| Q47858629 | Nanotechnology in neurosurgery: thinking small, dreaming big. |
| Q46757158 | Neuro-protective effects of cerium and yttrium oxide nanoparticles on high glucose-induced oxidative stress and apoptosis in undifferentiated PC12 cells. |
| Q24607533 | Novel vaccine development strategies for inducing mucosal immunity |
| Q90537794 | Phytochemical Analysis of Anti-Inflammatory and Antioxidant Effects of Mahonia aquifolium Flower and Fruit Extracts |
| Q36023685 | Recent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems |
| Q36460631 | Revolutionary Impact of Nanodrug Delivery on Neuroscience |
| Q38617018 | Stimuli-responsive nanogel composites and their application in nanomedicine |
| Q92860848 | Stroke Management: An Emerging Role of Nanotechnology |
| Q38864288 | Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration |
| Q26747319 | The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer |
| Q48098368 | The application of nanoparticles for neuroprotection in acute ischemic stroke |
| Q33812130 | The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase |
| Q57777403 | The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrier |
| Q46590704 | The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain |
| Q33751600 | The response effect of pheochromocytoma (PC12) cell lines to oxidized multi-walled carbon nanotubes (o-MWCMTs) |
| Q38201046 | Therapeutic application of nanotechnology in cardiovascular and pulmonary regeneration |
| Q37555829 | Uses of nanoparticles for central nervous system imaging and therapy |
| Q57340460 | Utility and Potential Application of Nanomaterials in Medicine |
| Q92445579 | Zebrafish as an Emerging Model for Bioassay-Guided Natural Product Drug Discovery for Neurological Disorders |
Search more.